This talk will focus on recent innovations in Bayesian phase I and II trials. A general discussion of innovative design strategies will be accompanied by multiple examples from straightforward CRM-like designs in phase 1 to designs involving multiple schedules and indications, and designs involving seamless shifts from phase I to phase II.